Research & Development



  “腰牌!”   “六百斤!”青青草视频   何愁有嘆息一聲道︰“果然好詩,只是,雲郎的這首詩不合樂府韻,稍微有些瑕疵。”久草在线新免费   春風二度,兩岸猿聲啼不住。   雲瑯想了片刻點點頭道︰“公孫弘他們的想法其實是沒錯的,天下好不容易被始皇帝弄成了郡縣制,你們這些沛人哪一家不是有成千上萬的封戶?那個家里的田土不是一望無際的?那個家里不是僕婢成群,那個不是醉生夢死的過活?確實該清理一下了。”任你操   曹襄有些悲傷地道︰“總要問問的,總要有個說道的,不能僅僅憑借高世青手上的一封信件就說我們沛人在背著太祖高皇帝操弄整個大漢吧?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo